Does Bismuth Subcitrate Potassium Metronidazole And Tetracycline Interact with Warfarin?
Bismuth Subcitrate Potassium Metronidazole And Tetracycline and Warfarin have a major drug interaction according to U.S. FDA drug labeling data. Potentiation of anticoagulant effect with prolongation of prothrombin time; closely monitor prothrombin time, INR, and monitor for bleeding. The mechanism involves metronidazole potentiates anticoagulant effect; tetracycline depresses plasma prothrombin activity. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Major
- Bismuth Subcitrate Potassium Metronidazole And Tetracycline Class
- Nitroimidazole Antimicrobial
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Bismuth Subcitrate Potassium Metronidazole And Tetracycline and Warfarin occurs because metronidazole potentiates anticoagulant effect; tetracycline depresses plasma prothrombin activity. Clinically, this means potentiation of anticoagulant effect with prolongation of prothrombin time; closely monitor prothrombin time, inr, and monitor for bleeding. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.
What To Tell Your Doctor or Pharmacist
If you are taking Bismuth Subcitrate Potassium Metronidazole And Tetracycline and your doctor is considering prescribing Warfarin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider